Low apparent risk of CCNU (lomustine)-associated clinical hepatotoxicity in cats

Journal of Feline Medicine and Surgery

Volumn 14, Issue 12, 2012, Pages 871-875

  Musser, Margaret L ^a   Quinn, Hilary T ^a   Chretin, John D ^a  

^a USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKYLATING AGENT; LOMUSTINE;

ANIMAL; ANIMAL DISEASE; CAT; CAT DISEASE; DOSE RESPONSE; FEMALE; MALE; METABOLISM; NEOPLASM; REVIEW; RISK FACTOR; TOXIC HEPATITIS; UNITED STATES;

ALANINE TRANSAMINASE; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CAT DISEASES; CATS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; FEMALE; LOMUSTINE; MALE; NEOPLASMS; RISK FACTORS; UNITED STATES;

EID: 84870231284     PISSN: 1098612X     EISSN: 15322750     Source Type: Journal    
DOI: 10.1177/1098612X12453836     Document Type: Review

References (22)

1. Oliverio VT,Vietzke WM,Williams MK, et al.The absorption, distribution, excretion and biotransformation of the carcinostatic 1-(-2-Chloroethyl)-3-cyclohexyl-1-nitrosurea in animals.Am Assoc Cancer Res. 170 (30): 1330-1337.
2. Weiss RB,Issell BF.The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).Cancer Treat Rev. 1982;9:313-330.
3. Moore AS,Kitchell BE.New chemotherapy agents in veterinary medicine.Vet Clin Small Anim Pract. 2003;33:629-649.
4. Fan TM,Kitchell BE,Dhaliwal RS, et al.Hematological toxicity and therapeutic efficacy of lomustine in 20 tumor-bearing cats: critical assessment of a practical dosing regimen.J Am Anim Hosp Assoc. 2002;38:357-363.
5. Kristal O,Rassnick KM,Gliatto JM, et al.Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs.J Vet Intern Med. 2004;18:75-80.
6. Komori S,Nakamura S,Takahashi K, et al.Use of lomustine to treat cutaneous nonepitheliotropic lymphoma in a cat.J Am Vet Assoc. 2005;226:237-239.
7. Van Meervenne SAE,de Vos JP,Van Ham L, et al.Comparative aspects of pulmonary toxicity induced by cytotoxic agents with emphasis on lomustine, and a veterinary case report.Vlaams Diergeneeskundig Tijdschrift. 2008;77:248-255.
8. Moore AS,London CA,Wood CA, et al.Lomustine (CCNU) for the treatment of resistant lymphoma in dogs.J Vet Intern Med. 1999;13:395-398.
9. Rassnick KM,Bailey DB,Russell DS, et al.A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or non-resectable mast cell tumors.Vet Comp Oncol. 2010;8:138-152.
10. Senior JR.Monitoring for hepatotoxicity: what is the predictive value of liver 'function' tests?.Clin Pharmacol Ther. 2009;85:331-334.
11. Hosoya K,Lord LK,Lara-Garcia, et al.Prevalence of elevated alanine transaminase activity in dogs treated with CCNU (lomustine).Vet Comp Oncol. 2009;7:244-255.
12. Carter SK,Newman JW.Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosoure (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-chyclohexyl-1-nitrosourea (NSC-79037; CCNU) - clinical brochure.Cancer Chemother Rep. 1968;1:115-151.
13. Hoogstraten B,Gottlieb JA,Caoili E, et al.CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study.Cancer. 1973;32:38-43.
14. Ettinger SJ,Feldman ECFathom LGower J, ed. St. Louis, MO: Elsevier, Saunders; 2010:1614-1616.
15. Rassnick KM,Gieger TL,Williams LE, et al.Phase I evaluation of CCNU (lomustine) in tumor-bearing cats.J Vet Intern Med. 2001;15:196-199.
16. Rassnick KM,Williams LE,Kristal O, et al.Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005).J Am Vet Med Assoc. 2008;232:1200-1205.
17. Skorupski KA,Durham AC,Duda L, et al.Pulmonary fibrosis after high cumulative dose nitrosourea chemotherapy in a cat.Vet Comp Oncol. 2008;6:120-125.
18. Biller DS,Kantrowitz B.Ultrasonography of diffuse liver disease.J Vet Intern Med. 1992;6:71-76.
19. Khan S,Ramwani JJ,O'Brien PJ.Hepatocyte toxicity of mechlorethamine and other alkylating anticancer drugs.Biochem Pharmacol. 1992;43:1963-1967.
20. Kretschmer NW,Boor PJ,Azhary RA, et al.Studies on the mechanism of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrusourea (CCNU) - induced hepatotoxicity.Cancer Chemother Pharmacol. 1987;19:109-117.
21. Hill DL,Kirk MC,Struck RF.Microsomal metabolism of nitrosoureas.Am Assoc Cancer Res. 1975;35:296-301.
22. Lowe AD,Campbell KL,Barger A, et al.Clinical, clincopathological and histological changes observed in 14 cats treated with glucocorticoids.Vet Rec. 2008;162:777-783.